Representative before the EPO

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

We have observed 7 EP applications Gustavo Fuster has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12780132

USE OF A COMPOSITION COMPRISING A POLY-ORGANOSILOXANE

IPC classification:
A61L 31/06, A61K 31/695, A61N 5/10
Applicant:
Servicio Andaluz de Salud
Agent:
Manuel Illescas, Manuel Illescas y Asociados SL
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
GRANT OF PATENT INTENDED
EP12857270

METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF ACUTE RENAL DAMAGE

IPC classification:
C12Q 1/68
Applicant:
Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Agent:
Ignacio Temino Ceniceros, Abril Abogados
Status:
EXAMINATION IN PROGRESS
EP13785891

BETA-3 ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61K 31/63, A61K 31/5517, A61K 31/55, A61K 31/4412, A61K 31/426, A61K 31/36, A61K 31/216, A61K 31/195, A61P 11/00
Applicant:
Hospital Clínic de Barcelona
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
GRANT OF PATENT INTENDED
EP14748175

METHOD FOR PREDICTING TREATMENT RESPONSE AND TEST FOR SAFE USE OF MESENCHYMAL STEM CELLS ON INFLAMMATORY DISEASES.

IPC classification:
C12N 5/00, G01N 33/86
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
The patent has been granted
EP14844286

COMBINATIONS OF AGGREGATING PROTEINS AND MOLECULAR CHAPERONE PROTEINS FOR THE TREATMENT OF PROTEINOPATHIES OR CONFORMATIONAL DISEASES

IPC classification:
A61P 25/16, A61K 39/395, C07K 16/18, A61K 38/17
Applicant:
Universidad de Sevilla
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
GRANT OF PATENT INTENDED
EP14848032

METHOD FOR PREDICTING THE RESPONSE TO CHEMOTHERAPY TREATMENT IN PATIENTS SUFFERING FROM COLORECTAL CANCER

IPC classification:
C12Q 1/68
Applicant:
Universidad de Sevilla
Applicant:
Servicio Andaluz de Salud
Applicant:
Consejo Superior De Investigaciones Científicas (CSIC)
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
GRANT OF PATENT INTENDED
EP14780863

STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN

IPC classification:
A61K 31/00, A61K 9/19
Applicant:
DSM Sinochem Pharmaceuticals Netherlands B.V.
Applicant:
Galenicum Health S.L.
Agent:
Gustavo Fuster, Hoffmann Eitle PartmbB
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature